will medicaid cover glp 1 for weight loss covers GLP-1 weight-loss drugs in just 13 states Could Maryland expand access to

This is not just about the number on the scalesits about reclaiming health and vitality

and internationally

Despite Harvard Medical School research published in July 2024 showing diabetes patients prescribed semaglutide faced over four times higher NAION risk (and weight loss patients faced over seven times higher risk) Novo Nordisks current Ozempic and Wegovy labels still mention only generic vision changes without specifically identifying NAION or permanent blindness as known risks

This isn't a sales pitch

Wang, Q., Wang, D., Cheng, A., Sun, F

A reduced risk of prostate cancer has been suggested in association with treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) [2,3,4,5], which are indicated for type 2 diabetes and obesity [6,7,8]